1 Introduction to Research & Analysis Reports
1.1 mRNA Vaccines and mRNA Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global mRNA Vaccines and mRNA Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global mRNA Vaccines and mRNA Drugs Overall Market Size
2.1 Global mRNA Vaccines and mRNA Drugs Market Size: 2022 VS 2029
2.2 Global mRNA Vaccines and mRNA Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global mRNA Vaccines and mRNA Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top mRNA Vaccines and mRNA Drugs Players in Global Market
3.2 Top Global mRNA Vaccines and mRNA Drugs Companies Ranked by Revenue
3.3 Global mRNA Vaccines and mRNA Drugs Revenue by Companies
3.4 Global mRNA Vaccines and mRNA Drugs Sales by Companies
3.5 Global mRNA Vaccines and mRNA Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 mRNA Vaccines and mRNA Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers mRNA Vaccines and mRNA Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 mRNA Vaccines and mRNA Drugs Players in Global Market
3.8.1 List of Global Tier 1 mRNA Vaccines and mRNA Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 mRNA Vaccines and mRNA Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global mRNA Vaccines and mRNA Drugs Market Size Markets, 2022 & 2029
4.1.2 Vaccine
4.1.3 API
4.2 By Type – Global mRNA Vaccines and mRNA Drugs Revenue & Forecasts
4.2.1 By Type – Global mRNA Vaccines and mRNA Drugs Revenue, 2018-2023
4.2.2 By Type – Global mRNA Vaccines and mRNA Drugs Revenue, 2024-2029
4.2.3 By Type – Global mRNA Vaccines and mRNA Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global mRNA Vaccines and mRNA Drugs Sales & Forecasts
4.3.1 By Type – Global mRNA Vaccines and mRNA Drugs Sales, 2018-2023
4.3.2 By Type – Global mRNA Vaccines and mRNA Drugs Sales, 2024-2029
4.3.3 By Type – Global mRNA Vaccines and mRNA Drugs Sales Market Share, 2018-2029
4.4 By Type – Global mRNA Vaccines and mRNA Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global mRNA Vaccines and mRNA Drugs Market Size, 2022 & 2029
5.1.2 Infectious Disease
5.1.3 Cancer
5.2 By Application – Global mRNA Vaccines and mRNA Drugs Revenue & Forecasts
5.2.1 By Application – Global mRNA Vaccines and mRNA Drugs Revenue, 2018-2023
5.2.2 By Application – Global mRNA Vaccines and mRNA Drugs Revenue, 2024-2029
5.2.3 By Application – Global mRNA Vaccines and mRNA Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global mRNA Vaccines and mRNA Drugs Sales & Forecasts
5.3.1 By Application – Global mRNA Vaccines and mRNA Drugs Sales, 2018-2023
5.3.2 By Application – Global mRNA Vaccines and mRNA Drugs Sales, 2024-2029
5.3.3 By Application – Global mRNA Vaccines and mRNA Drugs Sales Market Share, 2018-2029
5.4 By Application – Global mRNA Vaccines and mRNA Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global mRNA Vaccines and mRNA Drugs Market Size, 2022 & 2029
6.2 By Region – Global mRNA Vaccines and mRNA Drugs Revenue & Forecasts
6.2.1 By Region – Global mRNA Vaccines and mRNA Drugs Revenue, 2018-2023
6.2.2 By Region – Global mRNA Vaccines and mRNA Drugs Revenue, 2024-2029
6.2.3 By Region – Global mRNA Vaccines and mRNA Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global mRNA Vaccines and mRNA Drugs Sales & Forecasts
6.3.1 By Region – Global mRNA Vaccines and mRNA Drugs Sales, 2018-2023
6.3.2 By Region – Global mRNA Vaccines and mRNA Drugs Sales, 2024-2029
6.3.3 By Region – Global mRNA Vaccines and mRNA Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America mRNA Vaccines and mRNA Drugs Revenue, 2018-2029
6.4.2 By Country – North America mRNA Vaccines and mRNA Drugs Sales, 2018-2029
6.4.3 US mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.4.4 Canada mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.4.5 Mexico mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe mRNA Vaccines and mRNA Drugs Revenue, 2018-2029
6.5.2 By Country – Europe mRNA Vaccines and mRNA Drugs Sales, 2018-2029
6.5.3 Germany mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.5.4 France mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.5.5 U.K. mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.5.6 Italy mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.5.7 Russia mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.5.8 Nordic Countries mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.5.9 Benelux mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia mRNA Vaccines and mRNA Drugs Revenue, 2018-2029
6.6.2 By Region – Asia mRNA Vaccines and mRNA Drugs Sales, 2018-2029
6.6.3 China mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.6.4 Japan mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.6.5 South Korea mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.6.6 Southeast Asia mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.6.7 India mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America mRNA Vaccines and mRNA Drugs Revenue, 2018-2029
6.7.2 By Country – South America mRNA Vaccines and mRNA Drugs Sales, 2018-2029
6.7.3 Brazil mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.7.4 Argentina mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa mRNA Vaccines and mRNA Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa mRNA Vaccines and mRNA Drugs Sales, 2018-2029
6.8.3 Turkey mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.8.4 Israel mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.8.6 UAE mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Thermo Fisher
7.1.1 Thermo Fisher Company Summary
7.1.2 Thermo Fisher Business Overview
7.1.3 Thermo Fisher mRNA Vaccines and mRNA Drugs Major Product Offerings
7.1.4 Thermo Fisher mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Thermo Fisher Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck mRNA Vaccines and mRNA Drugs Major Product Offerings
7.2.4 Merck mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Merck Key News & Latest Developments
7.3 Qiagen N.V.
7.3.1 Qiagen N.V. Company Summary
7.3.2 Qiagen N.V. Business Overview
7.3.3 Qiagen N.V. mRNA Vaccines and mRNA Drugs Major Product Offerings
7.3.4 Qiagen N.V. mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Qiagen N.V. Key News & Latest Developments
7.4 CureVac
7.4.1 CureVac Company Summary
7.4.2 CureVac Business Overview
7.4.3 CureVac mRNA Vaccines and mRNA Drugs Major Product Offerings
7.4.4 CureVac mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.4.5 CureVac Key News & Latest Developments
7.5 In-Cell-Art
7.5.1 In-Cell-Art Company Summary
7.5.2 In-Cell-Art Business Overview
7.5.3 In-Cell-Art mRNA Vaccines and mRNA Drugs Major Product Offerings
7.5.4 In-Cell-Art mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.5.5 In-Cell-Art Key News & Latest Developments
7.6 eTheRNA
7.6.1 eTheRNA Company Summary
7.6.2 eTheRNA Business Overview
7.6.3 eTheRNA mRNA Vaccines and mRNA Drugs Major Product Offerings
7.6.4 eTheRNA mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.6.5 eTheRNA Key News & Latest Developments
7.7 Takara Bio Inc.
7.7.1 Takara Bio Inc. Company Summary
7.7.2 Takara Bio Inc. Business Overview
7.7.3 Takara Bio Inc. mRNA Vaccines and mRNA Drugs Major Product Offerings
7.7.4 Takara Bio Inc. mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Takara Bio Inc. Key News & Latest Developments
7.8 Sangamo Therapeutics
7.8.1 Sangamo Therapeutics Company Summary
7.8.2 Sangamo Therapeutics Business Overview
7.8.3 Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Major Product Offerings
7.8.4 Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Sangamo Therapeutics Key News & Latest Developments
7.9 Roche CustomBiotech
7.9.1 Roche CustomBiotech Company Summary
7.9.2 Roche CustomBiotech Business Overview
7.9.3 Roche CustomBiotech mRNA Vaccines and mRNA Drugs Major Product Offerings
7.9.4 Roche CustomBiotech mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Roche CustomBiotech Key News & Latest Developments
7.10 BioNTech
7.10.1 BioNTech Company Summary
7.10.2 BioNTech Business Overview
7.10.3 BioNTech mRNA Vaccines and mRNA Drugs Major Product Offerings
7.10.4 BioNTech mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.10.5 BioNTech Key News & Latest Developments
7.11 Tiba Biotechnology
7.11.1 Tiba Biotechnology Company Summary
7.11.2 Tiba Biotechnology Business Overview
7.11.3 Tiba Biotechnology mRNA Vaccines and mRNA Drugs Major Product Offerings
7.11.4 Tiba Biotechnology mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Tiba Biotechnology Key News & Latest Developments
7.12 TriLink Bio Technologies
7.12.1 TriLink Bio Technologies Company Summary
7.12.2 TriLink Bio Technologies Business Overview
7.12.3 TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Major Product Offerings
7.12.4 TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.12.5 TriLink Bio Technologies Key News & Latest Developments
7.13 Argos Therapeutics
7.13.1 Argos Therapeutics Company Summary
7.13.2 Argos Therapeutics Business Overview
7.13.3 Argos Therapeutics mRNA Vaccines and mRNA Drugs Major Product Offerings
7.13.4 Argos Therapeutics mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Argos Therapeutics Key News & Latest Developments
7.14 Moderna Therapeutics
7.14.1 Moderna Therapeutics Company Summary
7.14.2 Moderna Therapeutics Business Overview
7.14.3 Moderna Therapeutics mRNA Vaccines and mRNA Drugs Major Product Offerings
7.14.4 Moderna Therapeutics mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Moderna Therapeutics Key News & Latest Developments
7.15 NEB
7.15.1 NEB Company Summary
7.15.2 NEB Business Overview
7.15.3 NEB mRNA Vaccines and mRNA Drugs Major Product Offerings
7.15.4 NEB mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.15.5 NEB Key News & Latest Developments
7.16 Ethris
7.16.1 Ethris Company Summary
7.16.2 Ethris Business Overview
7.16.3 Ethris mRNA Vaccines and mRNA Drugs Major Product Offerings
7.16.4 Ethris mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.16.5 Ethris Key News & Latest Developments
7.17 Aldevron
7.17.1 Aldevron Company Summary
7.17.2 Aldevron Business Overview
7.17.3 Aldevron mRNA Vaccines and mRNA Drugs Major Product Offerings
7.17.4 Aldevron mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.17.5 Aldevron Key News & Latest Developments
7.18 Promega
7.18.1 Promega Company Summary
7.18.2 Promega Business Overview
7.18.3 Promega mRNA Vaccines and mRNA Drugs Major Product Offerings
7.18.4 Promega mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.18.5 Promega Key News & Latest Developments
7.19 Translate Bio
7.19.1 Translate Bio Company Summary
7.19.2 Translate Bio Business Overview
7.19.3 Translate Bio mRNA Vaccines and mRNA Drugs Major Product Offerings
7.19.4 Translate Bio mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.19.5 Translate Bio Key News & Latest Developments
8 Global mRNA Vaccines and mRNA Drugs Production Capacity, Analysis
8.1 Global mRNA Vaccines and mRNA Drugs Production Capacity, 2018-2029
8.2 mRNA Vaccines and mRNA Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global mRNA Vaccines and mRNA Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 mRNA Vaccines and mRNA Drugs Supply Chain Analysis
10.1 mRNA Vaccines and mRNA Drugs Industry Value Chain
10.2 mRNA Vaccines and mRNA Drugs Upstream Market
10.3 mRNA Vaccines and mRNA Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 mRNA Vaccines and mRNA Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Table 1. Key Players of mRNA Vaccines and mRNA Drugs in Global Market
Table 2. Top mRNA Vaccines and mRNA Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global mRNA Vaccines and mRNA Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global mRNA Vaccines and mRNA Drugs Revenue Share by Companies, 2018-2023
Table 5. Global mRNA Vaccines and mRNA Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global mRNA Vaccines and mRNA Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers mRNA Vaccines and mRNA Drugs Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers mRNA Vaccines and mRNA Drugs Product Type
Table 9. List of Global Tier 1 mRNA Vaccines and mRNA Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 mRNA Vaccines and mRNA Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global mRNA Vaccines and mRNA Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global mRNA Vaccines and mRNA Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global mRNA Vaccines and mRNA Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global mRNA Vaccines and mRNA Drugs Sales (K Units), 2024-2029
Table 16. By Application – Global mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global mRNA Vaccines and mRNA Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global mRNA Vaccines and mRNA Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global mRNA Vaccines and mRNA Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global mRNA Vaccines and mRNA Drugs Sales (K Units), 2024-2029
Table 21. By Region – Global mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global mRNA Vaccines and mRNA Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global mRNA Vaccines and mRNA Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global mRNA Vaccines and mRNA Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global mRNA Vaccines and mRNA Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America mRNA Vaccines and mRNA Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America mRNA Vaccines and mRNA Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe mRNA Vaccines and mRNA Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe mRNA Vaccines and mRNA Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia mRNA Vaccines and mRNA Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia mRNA Vaccines and mRNA Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America mRNA Vaccines and mRNA Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America mRNA Vaccines and mRNA Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa mRNA Vaccines and mRNA Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa mRNA Vaccines and mRNA Drugs Sales, (K Units), 2024-2029
Table 46. Thermo Fisher Company Summary
Table 47. Thermo Fisher mRNA Vaccines and mRNA Drugs Product Offerings
Table 48. Thermo Fisher mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Thermo Fisher Key News & Latest Developments
Table 50. Merck Company Summary
Table 51. Merck mRNA Vaccines and mRNA Drugs Product Offerings
Table 52. Merck mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Merck Key News & Latest Developments
Table 54. Qiagen N.V. Company Summary
Table 55. Qiagen N.V. mRNA Vaccines and mRNA Drugs Product Offerings
Table 56. Qiagen N.V. mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Qiagen N.V. Key News & Latest Developments
Table 58. CureVac Company Summary
Table 59. CureVac mRNA Vaccines and mRNA Drugs Product Offerings
Table 60. CureVac mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. CureVac Key News & Latest Developments
Table 62. In-Cell-Art Company Summary
Table 63. In-Cell-Art mRNA Vaccines and mRNA Drugs Product Offerings
Table 64. In-Cell-Art mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. In-Cell-Art Key News & Latest Developments
Table 66. eTheRNA Company Summary
Table 67. eTheRNA mRNA Vaccines and mRNA Drugs Product Offerings
Table 68. eTheRNA mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. eTheRNA Key News & Latest Developments
Table 70. Takara Bio Inc. Company Summary
Table 71. Takara Bio Inc. mRNA Vaccines and mRNA Drugs Product Offerings
Table 72. Takara Bio Inc. mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Takara Bio Inc. Key News & Latest Developments
Table 74. Sangamo Therapeutics Company Summary
Table 75. Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Product Offerings
Table 76. Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Sangamo Therapeutics Key News & Latest Developments
Table 78. Roche CustomBiotech Company Summary
Table 79. Roche CustomBiotech mRNA Vaccines and mRNA Drugs Product Offerings
Table 80. Roche CustomBiotech mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Roche CustomBiotech Key News & Latest Developments
Table 82. BioNTech Company Summary
Table 83. BioNTech mRNA Vaccines and mRNA Drugs Product Offerings
Table 84. BioNTech mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. BioNTech Key News & Latest Developments
Table 86. Tiba Biotechnology Company Summary
Table 87. Tiba Biotechnology mRNA Vaccines and mRNA Drugs Product Offerings
Table 88. Tiba Biotechnology mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Tiba Biotechnology Key News & Latest Developments
Table 90. TriLink Bio Technologies Company Summary
Table 91. TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Product Offerings
Table 92. TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. TriLink Bio Technologies Key News & Latest Developments
Table 94. Argos Therapeutics Company Summary
Table 95. Argos Therapeutics mRNA Vaccines and mRNA Drugs Product Offerings
Table 96. Argos Therapeutics mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Argos Therapeutics Key News & Latest Developments
Table 98. Moderna Therapeutics Company Summary
Table 99. Moderna Therapeutics mRNA Vaccines and mRNA Drugs Product Offerings
Table 100. Moderna Therapeutics mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Moderna Therapeutics Key News & Latest Developments
Table 102. NEB Company Summary
Table 103. NEB mRNA Vaccines and mRNA Drugs Product Offerings
Table 104. NEB mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. NEB Key News & Latest Developments
Table 106. Ethris Company Summary
Table 107. Ethris mRNA Vaccines and mRNA Drugs Product Offerings
Table 108. Ethris mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 109. Ethris Key News & Latest Developments
Table 110. Aldevron Company Summary
Table 111. Aldevron mRNA Vaccines and mRNA Drugs Product Offerings
Table 112. Aldevron mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 113. Aldevron Key News & Latest Developments
Table 114. Promega Company Summary
Table 115. Promega mRNA Vaccines and mRNA Drugs Product Offerings
Table 116. Promega mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 117. Promega Key News & Latest Developments
Table 118. Translate Bio Company Summary
Table 119. Translate Bio mRNA Vaccines and mRNA Drugs Product Offerings
Table 120. Translate Bio mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 121. Translate Bio Key News & Latest Developments
Table 122. mRNA Vaccines and mRNA Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 123. Global mRNA Vaccines and mRNA Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 124. Global mRNA Vaccines and mRNA Drugs Production by Region, 2018-2023 (K Units)
Table 125. Global mRNA Vaccines and mRNA Drugs Production by Region, 2024-2029 (K Units)
Table 126. mRNA Vaccines and mRNA Drugs Market Opportunities & Trends in Global Market
Table 127. mRNA Vaccines and mRNA Drugs Market Drivers in Global Market
Table 128. mRNA Vaccines and mRNA Drugs Market Restraints in Global Market
Table 129. mRNA Vaccines and mRNA Drugs Raw Materials
Table 130. mRNA Vaccines and mRNA Drugs Raw Materials Suppliers in Global Market
Table 131. Typical mRNA Vaccines and mRNA Drugs Downstream
Table 132. mRNA Vaccines and mRNA Drugs Downstream Clients in Global Market
Table 133. mRNA Vaccines and mRNA Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. mRNA Vaccines and mRNA Drugs Segment by Type in 2022
Figure 2. mRNA Vaccines and mRNA Drugs Segment by Application in 2022
Figure 3. Global mRNA Vaccines and mRNA Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global mRNA Vaccines and mRNA Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global mRNA Vaccines and mRNA Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. mRNA Vaccines and mRNA Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by mRNA Vaccines and mRNA Drugs Revenue in 2022
Figure 9. By Type - Global mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global mRNA Vaccines and mRNA Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global mRNA Vaccines and mRNA Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global mRNA Vaccines and mRNA Drugs Price (US$/Unit), 2018-2029
Figure 13. By Application - Global mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global mRNA Vaccines and mRNA Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global mRNA Vaccines and mRNA Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global mRNA Vaccines and mRNA Drugs Price (US$/Unit), 2018-2029
Figure 17. By Region - Global mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global mRNA Vaccines and mRNA Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global mRNA Vaccines and mRNA Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global mRNA Vaccines and mRNA Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America mRNA Vaccines and mRNA Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America mRNA Vaccines and mRNA Drugs Sales Market Share, 2018-2029
Figure 23. US mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe mRNA Vaccines and mRNA Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe mRNA Vaccines and mRNA Drugs Sales Market Share, 2018-2029
Figure 28. Germany mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia mRNA Vaccines and mRNA Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia mRNA Vaccines and mRNA Drugs Sales Market Share, 2018-2029
Figure 37. China mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America mRNA Vaccines and mRNA Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America mRNA Vaccines and mRNA Drugs Sales Market Share, 2018-2029
Figure 44. Brazil mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa mRNA Vaccines and mRNA Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Market Share, 2018-2029
Figure 48. Turkey mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global mRNA Vaccines and mRNA Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production mRNA Vaccines and mRNA Drugs by Region, 2022 VS 2029
Figure 54. mRNA Vaccines and mRNA Drugs Industry Value Chain
Figure 55. Marketing Channels
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer